These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36972652)

  • 1. "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site.
    Perlmutter D; Wettemann C; Fockele CE; Frohe T; Williams W; Holland N; Oliphant-Wells T; Meischke H; van Draanen J
    Int J Drug Policy; 2023 May; 115():104005. PubMed ID: 36972652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
    Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
    Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile supervised consumption services in Rural British Columbia: lessons learned.
    Mema SC; Frosst G; Bridgeman J; Drake H; Dolman C; Lappalainen L; Corneil T
    Harm Reduct J; 2019 Jan; 16(1):4. PubMed ID: 30634986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges, Skepticism, and Recommendations from Police about Working in Collaboration with Supervised Consumption Services.
    Strike C; Watson TM; Altenberg J; Barnaby L; Bayoumi AM; Challacombe L; Demel G; Hopkins S; Wright A
    Subst Use Misuse; 2020; 55(12):1919-1924. PubMed ID: 32660302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative comparison of how people who use drugs' perceptions and experiences of policing affect supervised consumption services access in two cities.
    Urbanik MM; Maier K; Greene C
    Int J Drug Policy; 2022 Jun; 104():103671. PubMed ID: 35413583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.
    Bardwell G; Austin T; Maher L; Boyd J
    Harm Reduct J; 2021 Mar; 18(1):29. PubMed ID: 33678163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services.
    Ivsins A; Warnock A; Small W; Strike C; Kerr T; Bardwell G
    Int J Drug Policy; 2023 Jan; 111():103910. PubMed ID: 36436364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
    Khair S; Eastwood CA; Lu M; Jackson J
    Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study.
    Ali F; Russell C; Kaura A; Leslie P; Bayoumi AM; Hopkins S; Wells S
    PLoS One; 2023; 18(10):e0292862. PubMed ID: 37844109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies.
    Kryszajtys DT; Xavier J; Rudzinski K; Guta A; Chan Carusone S; Strike CJ
    Drug Alcohol Depend; 2022 Jan; 230():109179. PubMed ID: 34847503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "It's just not the same": Exploring PWUD' perceptions of and experiences with drug policy and SCS services change in a Canadian City.
    Greene C; Maier K; Urbanik MM
    Int J Drug Policy; 2023 Jan; 111():103934. PubMed ID: 36549200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rules and Eligibility Criteria for Supervised Consumption Services Feasibility Studies - A Scoping Review.
    Xavier J; Rudzinski K; Guta A; Carusone SC; Strike C
    Int J Drug Policy; 2021 Feb; 88():103040. PubMed ID: 33220597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation contexts and the impact of policing on access to supervised consumption services in Toronto, Canada: a qualitative comparative analysis.
    Bardwell G; Strike C; Altenberg J; Barnaby L; Kerr T
    Harm Reduct J; 2019 May; 16(1):30. PubMed ID: 31046759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: a quantitative systematic review protocol.
    Clarke DE; Gonzalez M; Pereira A; Boyce-Gaudreau K; Waldman C; Demczuk L
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):133-45. PubMed ID: 26571289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
    Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticipated use of a supervised drug consumption site among syringe services program clients in King County, Washington: Assessing the role of opioid overdose and injection behavior.
    Klein KS; Glick SN; Mauro PM
    Drug Alcohol Depend; 2020 Aug; 213():108121. PubMed ID: 32585421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "You don't have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care.
    Kosteniuk B; Salvalaggio G; McNeil R; Brooks HL; Dong K; Twan S; Brouwer J; Hyshka E
    Int J Drug Policy; 2021 Oct; 96():103275. PubMed ID: 34020865
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.